
|Articles|November 15, 2002
Timolol hemihydrate offers brand-name efficacy as beta-blocker
Newark, NJ-Timolol hemihydrate (Betimol, Santen Inc.) is an excellent choice when a beta-blocker is indicated for IOP-lowering in patients with ocular hypertension or glaucoma, said Paul J. Lama, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement




























